Cell Death and Disease (May 2024)

XIST and MUC1-C form an auto-regulatory pathway in driving cancer progression

  • Keyi Wang,
  • Atrayee Bhattacharya,
  • Naoki Haratake,
  • Tatsuaki Daimon,
  • Ayako Nakashoji,
  • Hiroki Ozawa,
  • Bo Peng,
  • Wei Li,
  • Donald Kufe

DOI
https://doi.org/10.1038/s41419-024-06684-9
Journal volume & issue
Vol. 15, no. 5
pp. 1 – 12

Abstract

Read online

Abstract The long non-coding RNA X-inactive specific transcript (lncRNA XIST) and MUC1 gene are dysregulated in chronic inflammation and cancer; however, there is no known interaction of their functions. The present studies demonstrate that MUC1-C regulates XIST lncRNA levels by suppressing the RBM15/B, WTAP and METTL3/14 components of the m6A methylation complex that associate with XIST A repeats. MUC1-C also suppresses the YTHDF2-CNOT1 deadenylase complex that recognizes m6A sites and contributes to XIST decay with increases in XIST stability and expression. In support of an auto-regulatory pathway, we show that XIST regulates MUC1-C expression by promoting NF-κB-mediated activation of the MUC1 gene. Of significance, MUC1-C and XIST regulate common genes associated with inflammation and stemness, including (i) miR-21 which is upregulated across pan-cancers, and (ii) TDP-43 which associates with the XIST E repeats. Our results further demonstrate that the MUC1-C/XIST pathway (i) is regulated by TDP-43, (ii) drives stemness-associated genes, and (iii) is necessary for self-renewal capacity. These findings indicate that the MUC1-C/XIST auto-regulatory axis is of importance in cancer progression.